Patient info

Lopresor SR 200 mg tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: No longer supplied Details

Medicine strength:
200 mg
Contains active substance:
ATC code:
Similar medicines:

Sources: Original (products.mhra.gov.uk)

Summary of Product Characteristics (SmPC) - Lopresor SR 200 mg tablets

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

Not applicable

4.2. Posology and method of administration

Not applicable

4.3. Contrain­dications

Not applicable

4.4. Special warnings and precautions for use

Not applicable

4.5. Interactions with other medicinal products and other forms of interaction

4.6. Pregnancy and lactation

Not applicable

4.7. Effects on ability to drive and use machines

Not applicable

4.8. Undesirable effects

Not applicable

4.9. Overdose

Not applicable

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmaco­dynamic properties

Not applicable

5.2. Pharmaco­kinetic properties

Not applicable

5.3. Preclinical safety data

Not applicable

Sources: Original (products.mhra.gov.uk)

Facts about Lopresor SR 200 mg tablets

Active substance Metoprolol
Strength 200 mg
Pharmaceutical form Modified-release tablet
How is it taken Oral
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. C Cardiovascular system drugs
    1. C07 Beta-Adrenergic Blocking Agents
      1. C07A Beta blocking agents
        1. C07AB Beta blocking agents, selective
          1. C07AB02 metoprolol
Codes BNF 02040000

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.